JREE:F:F-JPMorgan ETFs (Ireland) ICAV - Europe Research Enhanced Index Equity UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 42.985

Change

-0.29 (-0.67)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.18 (+0.65%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.41 (+0.80%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

+3.44 (+0.63%)

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.73 (-1.29%)

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.40 (+0.17%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.15 (+0.98%)

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.20 (+0.21%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.17 (+0.17%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.74B
0ZC:F Zscaler Inc

+0.76 (+0.50%)

USD 37.92B

ETFs Containing JREE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.83% 58% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.83% 55% F 55% F
Trailing 12 Months  
Capital Gain 20.22% 64% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.22% 61% D- 57% F
Trailing 5 Years  
Capital Gain 60.54% 76% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 60.54% 76% C+ 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 11.22% N/A N/A 72% C
Dividend Return 11.22% N/A N/A 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.70% N/A N/A 82% B
Risk Adjusted Return 88.37% N/A N/A 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike